Skip to main content

Table 1 Association between the expression level of miR-133a-3p or GAPARAPL1 and the clinical characteristics in GC patients

From: Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis

Parameters

Group

miR-133a-3p expression

GABARAPL1 expression

Cases

Low

High

P-value

Cases

Low

High

P-value

Gender

female

male

24

56

13

27

11

29

0.6256

15

35

7

18

8

17

0.7576

Age at surgery

≥ 55

<  55

64

16

29

11

35

5

0.0935

7

43

5

20

2

23

0.2214

T grade

T1 + T2

T3 + T4

45

35

21

19

24

16

0.4990

24

26

14

11

10

15

0.2575

Lymphatic invasion

Negative(N0)

Positiv(N1-N3)

23

57

7

33

16

24

0.0262*

20

30

12

13

8

17

0.2482

Tumor site

Cardiac

Non-cardiac

30

50

16

24

14

26

0.6442

18

32

12

13

6

19

0.0771

Stage

I-II

III-IV

41

39

18

22

23

17

0.2634

23

27

14

11

9

16

0.1560

Size(cm)

<  3

≥ 3

37

43

13

27

24

162

0.0136*

21

29

14

11

7

18

0.0449*

Histology grade

Well-moderately

Poorly-signet

25

55

15

25

10

30

0.2278 0.

17

33

10

15

7

18

0.3705

  1. P < 0.05 represents statistical significance (Chi-square test)